Background: This study examined the efficacy of the combination antioxidant, Formula 42 (F42), on cellular stress indicators in animal and human models of stress-induced oxidative stress. Methods: A sub-chronic psychological stress model in rodents was used to induce stress and oxidative stress indicators over a 10-day period during which animals received oral doses of F42 or water. Following treatment, body weight, plasma stress hormone corticosterone, and oxidative capacity were evaluated. In healthy human subjects, a randomized double-blind crossover study was used to examine the antioxidant effect of F42 or placebo in an exercise-induced oxidative stress model. Erythrocyte and plasma oxidative status was evaluated using the fluorescent activation of 2′,7′-dichlorofluorescin (DCF) as an indicator. Results: Oral administration of F42 reduced the corticosterone response to acute stress compared to vehicle but did not differ at the conclusion of the 10-day study. However, F42 administration did reduce stress-induced growth restriction and alleviate DCF activation in circulating erythrocytes by approximately 10% following 10 days of stress exposure. Oral administration of F42 also significantly reduced DCF activation by approximately 10% in healthy human subjects undergoing exercise-induced oxidative stress. Conclusions: Oral administration of F42 in rodents produces transient reductions in stress hormones and reduces
Introduction
The defensive response to a threatening situation activates the sympathetic nervous system within a few seconds, resulting in the 'flight-or-fight' response. It is well known that activity of the sympathetic nervous system results in the utilization of stored energy (adenosine tri-phosphate, ATP) by active cells of the heart, brain, and many other organs. This is driven by noradrenaline, which is mainly released from sympathetic nerve endings, and adrenaline from the adrenal medulla. Corticosteroids are subsequently released from the adrenal cortex, extending the effects of stress from minutes to hours [1, 2] . The main function of corticosteroids during an acute stressful situation is to restore the energy used during the 'fight-or-flight', which is achieved by the rapid mobilization of stored glucose [3] .
The liberated glucose produces cellular energy in the form of ATP by a process that utilizes oxygen, termed oxidative phosphorylation. A by-product of oxidative phosphorylation is the production of free radicals, including both reactive oxygen (ROS) and nitrogen (RNS) species [4, 5] . Increased production of these radicals following stress reacts with lipids, proteins, and DNA, resulting in oxidative stress [6] [7] [8] [9] [10] . It is this damage that leads to the development of pathophysiological conditions. To safeguard against damage by ROS/RNS, there is a sequestering mechanism involving a network of endogenous antioxidants including glutathione [11, 12] . This mechanism works well under normal conditions but exhausts quickly during prolonged stress exposure, which can lead to the development of a myriad of disorders such as hypertension, obesity, osteoporosis, immunosuppression, insomnia, anxiety, depression, and loss of memory and cognitive function [13] .
Recently, a number of small aliphatic alcohols and aldehydes isolated from green leaves have demonstrated reductions in stress indicators such as the adrenal hormone, corticosterone [14] . Although much of the research on these naturally occurring chemicals focuses on the effects of olfactory exposure, they are also found in fruits and vegetables that form part of our everyday diets. Dietary bioactive chemicals also include some highly potent antioxidant compounds such as anthocyanins. These chemicals can influence oxidative stress by entering the circulation and directly sequestering radicals within 30 min of ingestion [15] . In the present study, a combination of natural extracts from wheat grass, seeds, fruits, and vegetables, Formula 42 (F42), was assessed for efficacy in alleviating endocrine and cellular stress indicators following sub-chronic stress exposure in rodents. Furthermore, the acute antioxidative profile of F42 was then determined in healthy human subjects using a model of exercise-induced oxidative stress.
Materials and methods

Composition of F42
Formula 42 was prepared as a concentrate from commercially available freeze-dried extracts of berries, root vegetables, and wheatgrass, which together are known to be rich in flavonoids, anthocyanins, carotenoid, and chlorophyll. The concentrate was prepared by diluting with water on the day of each experiment.
Experimental animals
Inbred male BALB/c mice aged 6 weeks postnatal were sourced from the University of Queensland Biological Resources breeding colony. Animals were housed in groups of 4 under standard laboratory conditions (22±2 °C; 55±5% humidity) with a 12-h light-dark cycle (lights on at 07:00). Standard mouse chow and water were available ad libitum. All experimental procedures were in accordance with regulations and policies outlined by The University of Queensland Animal Ethics Committee with AEC approval number SBMS/186/12/URG.
Experimental protocol
Mice were habituated to human handling and the gavage procedure for 10 min/day over a 1-week period prior to experimentation. At the beginning of the 10-day treatment period, mice were weighed and allowed to acclimatize to the novel experimental room for 1 h and then randomly allocated to a treatment. The treatment groups were (1) control with water, (2) control with F42, (3) restraint stress with water, and (4) restraint stress with F42. Control animals were placed in treatment cages individually and administered either 0.5 mL water or F42 by gavage. They were kept in isolation for the same duration as animals that were restrained. Stressed animals were given 0.5 mL of water or F42 by gavage and subsequently placed in a metal cylinder measuring 2.5 cm (diameter) and 8 cm (length) for 2 h. This procedure was repeated for the 10-day treatment period, and blood samples were collected in 20 IU/mL of heparin following stress treatment via tail-tipping on days 1, 5, and 10. These samples were centrifuged at 1500 rpm for 5 min, and supernatant plasma was collected and stored at -80 °C for later determination of plasma corticosterone concentrations. At the end of the 10-day treatment, animals were weighed and sacrificed by cervical dislocation and a final blood was collected into ice-chilled heparinized (20 IU/mL) tubes from cardiac puncture and immediately centrifuged at 1500 rpm for 5 min. The remaining red blood cells were washed with excess phosphate-buffered saline (PBS; 50 mM, pH = 7.4) and stored on ice for determination of general oxidative status.
Plasma corticosterone assay
Plasma corticosterone concentrations were assayed using radioimmunoassay as per described by Spiers and colleagues. The interand intra-assay coefficients of variation were 6.33% and 5.76%, respectively.
General oxidative status assay in erythrocytes
General oxidative status in erythrocyte was measured fluorometrically using the 2′,7′-dichlorofluorescin diacetate (DCFH-DA) assay according to Spiers and colleagues. This method gives an indication of cellular oxidative status using freshly isolated erythrocytes. Sample fluorescence was measured by a POLARstar OPTIMA microplate reader (BMG Labtechnologies) with excitation and emission filters set at 485 nm and 520 nm, respectively. Data were expressed as the percentage change in arbitrary fluorescence units relative to control values.
Human studies
Healthy human subjects (n = 36; 19 females and 17 males, age range of 18-25) volunteered and gave written consent to take part in this study. The participants were instructed to fast for 2 h prior to the experiment and avoid strenuous exercise and foods high in sugar, fat, and multivitamins on days in which they participated in the experiment. All experimental procedures were in accordance with regulations and policies outlined by The University of Queensland Institutional Human Research Ethics approval number 2013001149.
Treatment protocol
Participants were randomly assigned into two double-blinded treatment groups, placebo or F42, with a crossover design over two sessions being 2 weeks apart. Finger-prick blood samples were collected into heparinized capillary tubes at rest (t = 0 min; baseline), post consumption of the allocated treatment (t = 30), post-exercise (t = 45), and following a 30-min recovery period (t = 75). Following the baseline samples, subjects were weighed and consumed their calculated loads (5 mL/kg of body weight) of placebo or F42. Subjects then performed exercise in the form of step-ups for 15 min at 80%-85% of their maximal heart rate. Blood samples were collected into heparinized hematocrit tubes and were immediately placed into ice-chilled test tubes prior to centrifugation at 1500 rpm for 5 min. The supernatant plasma was collected and stored at -80 °C for later determination of general oxidative status. Two weeks later, the experiment was repeated with each subject receiving the opposite treatment from session 1 and undertaking the same experimental protocol as described earlier (Figure 1 ).
General oxidative status in plasma
General oxidative status in plasma was measured fluorometrically using methods from Chen and colleagues. This method gives an indication of the overall oxidative status in circulation with the additional benefit of prolonged sample storage. Frozen plasma was rapidly defrosted, and a 1% (v/v) plasma suspension was prepared in ice-cold phosphate-buffered saline (50 mM, pH = 7.4). Four replicates were plated on a 96-well plate containing final concentrations of 0.5% (v/v) diluted plasma and 100 μM of DCFH-DA. Sample fluorescence was measured by a POLARstar OPTIMA microplate reader (BMG Labtechnologies). Data were corrected with corresponding protein concentrations in plasma and expressed as the percentage change in arbitrary fluorescence units relative to baseline values.
Protein determination
Plasma protein content was measured using a commercially available RED 660™ Protein Assay (G-Biosciences, St. Louis, MO, USA) using bovine serum albumin as standard.
Statistical analysis
Data were analyzed using statistical software GraphPad Prism (Version 5.0.3, GraphPad Software Inc., San Diego, CA, USA). 
Results
We have examined the plasma corticosterone levels from tail-tipped blood samples taken from mice at 1, 5, and 10 days of restraint stress exposure and compared these with controls with and without F42 (Figure 2 ). Samples collected on day 1 demonstrated a significant reduction (p < 0.05) in plasma corticosterone levels in the stressed animals that were treated with F42 (174.88±26.04 ng/ mL) when compared to the animals that received water (250.92±25.48 ng/mL). Following 10 days of 2-h restraint stress, we examined the change in body weights from these animals in response to the stressor ( Figure 3 ). There was a significant (p < 0.05) reduction in weight gain relative to pre-treatment when mice were exposed to subchronic stress (99.70±1.39%) compared to unrestrained controls (103.86±0.56%). This reduction in weight gain was alleviated in mice that were given F42 orally and was not significantly different from controls. Furthermore, the general oxidative status was examined from the end point blood samples following 10 days of sub-chronic restraint stress ( Figure 4 ). The stress exposure induced a significant (p < 0.001) increase in the levels of general oxidative status in animals that were given water prior to treatment (114.45±2.10%) when compared to controls (100±4.42%). Administration of F42 significantly alleviated the increase in general oxidative status observed following the subchronic restraint stress.
Having established that F42 is effective in reducing the impact of restraint stress both through a calming effect (reduction in plasma corticosterone levels) and reducing general oxidative status, we next examined the effect of F42 on healthy human subjects aged between 18 and 25 years ( Figure 5 ). F42 was orally administered at 5 mL/kg of body weight 30 min before exercise stress. Following consumption of F42, there was a reduction in the general oxidative status that reached significance at post-consumption (93.31±1.76%; p < 0.05) and post-exercise (89.49±1.98%; p < 0.01) when compared to subjects that received placebo at post-consumption (99.29±2.20%) and post-exercise (98.37±2.41%). The difference in oxidative state between placebo (106.10±3.31%) and F42 (98.05±2.25%)-treated subjects remained significant (p < 0.01) after a 30-min recovery period.
Discussion
In the present study, we have examined the effectiveness of F42 in reducing the physiological changes imposed by stress exposure of animals and humans. Stress exposure in mice reduced weight gain and increased the levels of glucocorticoids. Additionally, stress increased oxidative status in both animals and humans. These changes were significantly reduced when animals and human subjects were given F42 prior to stress exposure. In mice, the observed reduction in weight gain following 10 days of stress exposure in the water-treated group is consistent with previously reported literature demonstrating that prolonged stressors are capable of inducing metabolic/growth disturbances [16, 17] . Administration of F42 effectively alleviated stress-induced reductions in the normal weight gain of mice exposed to 10 days of psychological stress. Although this may be a result of early reductions in corticosterone concentrations, it is likely that other systems such as the sympathetic nervous system are also involved as stress-induced corticosterone levels did not differ at the end of the experiment. Interestingly, direct application of selective plant-derived chemicals or prior administration of F42 has demonstrated alleviating effects (Lavidis, unpublished observations) on the stress-induced increase in sympathetic neurotransmission, a system known to facilitate corticosterone secretion [18] [19] [20] . The overall fall in corticosterone levels over the duration of the experiment is typical of exposure to a predictable repeated stressor [21] . Odorous phytochemicals present in F42 have been well documented in reducing HPA axis activity following stress exposure and likely contribute to the initial decrease observed in this study [22] [23] [24] [25] [26] [27] [28] . Although the mechanism of these phytochemicals remains undetermined, the stress-reducing properties of exposure to them have been observed at all levels of the HPA axis. Alternatively, both the green chemicals and plant-derived antioxidants present in F42 may have a direct effect on corticosterone output by rapidly sequestering the intraadrenal free radical, nitric oxide, required for increasing adrenal sensitivity to adrenocorticotropic hormone [29] .
In the present study, F42 was effective in reducing the oxidative indicator of DCF activation in both mouse and human models. High concentrations of dietary bioactive compounds including carotenoids, flavonoids, anthocyanins, and derivatives of ellagic acid present in F42 are known to possess potent antioxidant activity and can act directly by sequestering free radicals through chemical interaction or indirectly via the stimulation of the endogenous antioxidant system. For example, the antioxidant and anti-inflammatory effects of anthocyanin pigments, such as those found in purple sweet potato, have been examined for therapeutic potential due to their preventative effect on age-induced neuronal apoptosis via cytochrome c inhibition and stimulatory effect on antioxidant enzymes such as superoxide dismutase and catalase [30] . Olejnick and colleagues [31] also demonstrated that high concentrations of anthocyanins in purple carrot extract were capable of reducing DCF activation in human colonic cells, even following gastrointestinal digestion. Using a rodent model, Koga and colleagues [32] showed that administration of grape seed extract significantly increased the resistance of circulating plasma to artificial oxidation. This study went on to demonstrate that this effect occurred within 15 min of extract administration and may be conferred by metabolites of gallic acid [32] . Nuttall and colleagues [15] also demonstrated antioxidant efficacy of a standardized commercial grape seed extract in humans. This study demonstrated that plasma total antioxidant capacity could be increased within 30 min of administration, with no loss of activity following daily administration for up to 5 days, the longest duration tested. Finally, Lyall and colleagues [33] showed that anthocyanin-rich black currant extract effectively suppressed exercise-induced oxidative stress in human plasma. Interestingly, this study also demonstrated a significant reduction in inflammatory cytokines when the extract was applied after induction of oxidative stress, an effect not observed when the extract was used prophylactically. In the present study, the rapid reduction in DCF activation during exercise highlights the effectiveness of F42 as an antioxidant formulation. However, in agreement with the conclusions of Lyall and colleagues [33] , the timing of antioxidant administration is an important consideration if these products are to have complementary effects with important physiological oxidative stress, such as the transient form induced by exercise.
The combination of plant-derived chemicals and antioxidants, F42, effectively reduces stress-induced growth restriction, corticosterone, and increases in plasma oxidative capacity when administered orally during stress exposure. Furthermore, oral administration in healthy human subjects indicates that F42 acts as a potent antioxidant in a model of exercise-induced oxidative stress, indicating that the timing of antioxidant administration should be an important consideration in healthy subjects for maximum complementary action. Future studies should elucidate the effects of administration in models of metabolic and neurological disorders, representing pathophysiological oxidative stress.
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